UCB reported 108M in Interest Expense on Debt for its fiscal semester ending in December of 2024.


Interest Expense On Debt Change Date
Alcon AG USD 49M 1000K Mar/2025
Amarin USD 3K 3K Dec/2024
argenx SE 1.13M 9K Jun/2025
AstraZeneca 303M 126M Jun/2025
Bayer 495M 89M Jun/2025
Galapagos EUR 780K 49.34M Mar/2025
Genmab DKK 9M 4M Jun/2025
GlaxoSmithKline 184M 22M Jun/2025
GRIFOLS EUR 202.71M 94.07M Jun/2024
Hikma Pharmaceutical 22M 9M Jun/2024
Lonza CHF 70M 11M Dec/2024
Merck 79M 1000K Jun/2025
Novartis USD 289M 19M Jun/2025
Orion 1.2M 200K Jun/2025
Recordati EUR 24.49M 6.41M Jun/2025
Roche Holding CHF 311.5M 1000K Dec/2024
Sanofi 148M 65M Jun/2025
UCB 108M 16M Dec/2024
Unibail Rodamco EUR 273.25M 65.05M Jun/2024